News Daily News For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis Yael L. Maxwell August 14, 2025
News Daily News FDA Warns of Air Embolism Risk With Watchman LAAO Access Systems Todd Neale August 06, 2025
News Conference News NY Valves 2025 Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication Todd Neale June 27, 2025
News Conference News NY Valves 2025 Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE Todd Neale June 27, 2025
News Daily News Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years Yael L. Maxwell June 09, 2025
News Daily News Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL Michael O'Riordan June 06, 2025
News Opinion Conversations in Cardiology Words of Wisdom for Early-Career Interventional Cardiologists June 03, 2025
News Conference News EuroPCR 2025 Early Coronary Function Testing Improves Quality of Life in ANOCA Yael L. Maxwell May 28, 2025
News Conference News EuroPCR 2025 Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis Michael O'Riordan May 22, 2025
News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Conference News SCAI 2025 BATMAN Signals New Way to Prevent LVOT Obstruction in High-Risk TMVR Patients L.A. McKeown May 07, 2025
News Daily News AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease Caitlin E. Cox May 06, 2025
News Daily News FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis Michael O'Riordan May 01, 2025
News Conference News ACC 2025 EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes L.A. McKeown April 07, 2025
News Opinion Conversations in Cardiology Cath Lab Attire: ‘Dress Up and Shut Up’ or Time for a Change? March 28, 2025
News Features What’s in a Name: Is It Time to Choose Between TAVI and TAVR? Yael L. Maxwell March 27, 2025
News Daily News ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients Michael O'Riordan March 26, 2025